Cargando…

Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors

Chimeric antigen receptor expression T (CAR-T) cell therapy has been shown be efficacious against relapsed/refractory B-cell malignant lymphoma and has attracted attention as an innovative cancer treatment. However, cells of solid tumors are less accessible to CAR-T cells; moreover, CAR-T function i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirobe, Sachiko, Nagai, Seina, Tachibana, Masashi, Okada, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220079/ https://www.ncbi.nlm.nih.gov/pubmed/35740295 http://dx.doi.org/10.3390/biomedicines10061273

Ejemplares similares

The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity
por: Hirobe, Sachiko, et al.
Publicado: (2022)

Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice
por: Hirobe, Sachiko, et al.
Publicado: (2021)

Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients
por: Fujiwara, Kento, et al.
Publicado: (2020)

Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells
por: Hirobe, Sachiko, et al.
Publicado: (2022)

ROBO1 CAR-T CELL THERAPY FOR TREATMENT REFRACTORY BRAIN CANCER
por: Shaikh, Muhammad Vaseem, et al.
Publicado: (2023)

Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathway
por: Li, Na, et al.
Publicado: (2020)

Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine delivery
por: Matsuo, Kazuhiko, et al.
Publicado: (2013)

A (90)Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
por: Fujiwara, Kentaro, et al.
Publicado: (2014)

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
por: Chen, Qiuqiang, et al.
Publicado: (2022)

Engineering CAR-T Cells for Improved Function Against Solid Tumors
por: Morgan, Michael A., et al.
Publicado: (2018)

Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
por: Ito, Sayami, et al.
Publicado: (2020)

Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy
por: Li, Hongjun, et al.
Publicado: (2021)

A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor
por: Sun, Shuyang, et al.
Publicado: (2023)

Lenalidomide Enhances CAR-T Cell Activity Against Solid Tumor Cells
por: Wang, Zhixiong, et al.
Publicado: (2020)

CAMEL NANOBODY-BASED B7-H3 CAR-T CELLS WITH HIGH EFFICACY AGAINST SOLID TUMORS
por: Li, Dan, et al.
Publicado: (2023)

Robo famélico
por: Patraca Polonio, Lizbeth María
Publicado: (2011)

Robo : un estudio descriptivo
por: González Sandoval, Patricia
Publicado: (1999)

Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors
por: Kosti, Paris, et al.
Publicado: (2021)

Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance
por: Qin, Yue, et al.
Publicado: (2022)

Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
por: Valiullina, Aigul Kh., et al.
Publicado: (2023)

Making CAR T Cells a Solid Option for Solid Tumors
por: Schmidts, Andrea, et al.
Publicado: (2018)

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
por: Portillo, Ana L., et al.
Publicado: (2021)

Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors
por: Jung, In-Young, et al.
Publicado: (2023)

Roadblocks to success for RNA CARs in solid tumors
por: Singh, Nathan, et al.
Publicado: (2015)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

CAR T Cell Locomotion in Solid Tumor Microenvironment
por: Nguyen, Duy T., et al.
Publicado: (2022)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
por: Ambrose, Christine, et al.
Publicado: (2021)

Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
por: Ghahri-Saremi, Navid, et al.
Publicado: (2021)

Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
por: Kyte, Jon Amund
Publicado: (2022)

Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors
por: Li, Feng, et al.
Publicado: (2019)

RoboCup 2013
por: Behnke, Sven, et al.
Publicado: (2014)

RoboCup 2018
por: Holz, Dirk, et al.
Publicado: (2019)

RoboCUP 2014
por: Bianchi, Reinaldo A C, et al.
Publicado: (2015)

Robo-investment aversion
por: Niszczota, Paweł, et al.
Publicado: (2020)

The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
por: Schaft, Niels
Publicado: (2020)

Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies
por: Lee, Boon kiat, et al.
Publicado: (2022)

PD-1(Hi) CAR-T cells provide superior protection against solid tumors
por: Sailer, Cooper J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ntjoehocb1a4nvchp89b9j08h